GENIUS Act vs MiCA: how US and EU stablecoin rules compare

The GENIUS Act and MiCA are the two most consequential stablecoin regulatory frameworks in force in 2026, and they answer the same underlying question — who may issue a stablecoin, and under what conditions — through structurally different legal architectures. The GENIUS Act is a dedicated US federal statute focused specifically on payment stablecoins: licensed issuance, full reserve backing in cash and short-dated Treasuries, and redemption rights, with no issuer-paid interest. MiCA is a broader EU regulation covering the wider crypto-asset market, inside which stablecoins are addressed as two specific categories — e-money tokens (EMTs), pegged to a single fiat currency, and asset-referenced tokens (ARTs), backed by a basket of assets — sitting alongside rules for exchanges, custodians and other crypto-asset service providers. The practical differences that architecture produces matter directly to any institution settling payments across both jurisdictions.

How does licensing work under each regime?

Under the GENIUS Act, only a licensed payment stablecoin issuer — a bank subsidiary, a federally qualified nonbank issuer, or a state-qualified issuer meeting equivalent standards — may issue a token using the "payment stablecoin" designation, with supervision split between federal and state regulators depending on issuer type. Under MiCA, issuing an e-money token requires authorisation as an electronic money institution or credit institution, while issuing an asset-referenced token requires a dedicated MiCA authorisation with its own capital, governance and reserve requirements. Existing issuers already operating in the EU before MiCA's stablecoin rules took effect were given a transitional window under Article 143 to continue operating while their full authorisation was processed — a window that closes 1 July 2026 in most member states, after which unauthorised issuers must obtain full authorisation or cease EU operations entirely.

How do the reserve and redemption rules compare?

Both frameworks converge on the same principle — reserves must be high-quality, liquid, and sufficient to meet redemption demand — but express it differently. The GENIUS Act requires 1:1 reserves held specifically in cash and short-dated US Treasury instruments, explicitly prohibiting issuer-paid interest on stablecoin holdings so the instrument cannot be marketed as a yield-bearing product. MiCA requires EMT and ART issuers to hold reserves that are segregated from the issuer's own assets, professionally managed, and structured to support redemption at par, with additional requirements around custody and, for larger ARTs, liquidity stress-testing. Both regimes give holders a redemption right against the issuer, but the supervisory mechanics — who checks compliance, how often, and what happens on failure — differ by jurisdiction and, within the EU, by member-state competent authority.

How does enforcement differ in practice?

MiCA enforcement has moved fast and been material: as of March 2026, EU regulators had issued more than €540 million in fines since the framework took effect, including a €62 million penalty against a single platform — the largest single fine to date. As of the same date, only 19 EMT issuers and 29 tokens had been authorised across 11 countries, a relatively small number set against the scale of the stablecoin market operating in or serving the EU, and major global stablecoins including USDT remain non-compliant with MiCA, forcing exchanges to delist them for EU users and fragmenting liquidity along jurisdictional lines. GENIUS Act enforcement in the US is comparatively early-stage: the framework is newer, issuer authorisation is still being built out, and the market has not yet seen an enforcement track record on the scale MiCA has produced.

The GENIUS Act and MiCA agree on the underlying principle — licensed issuance, full reserves, redemption rights — but they enforce it through different regulators, on different timelines, with consequences that do not automatically translate across the Atlantic.

What does this mean for a stablecoin used cross-border?

A stablecoin compliant under the GENIUS Act is not automatically MiCA-compliant, and vice versa — each framework requires its own authorisation, and neither recognises the other's licence as sufficient. In practice, this means the same token may be freely usable for a US institution and simultaneously delisted or restricted for an EU counterparty, exactly the situation major stablecoins issuers have faced with EU exchanges through 2025 and into 2026. For an institution settling payments across a US-EU corridor, this is not an abstract regulatory detail — it determines which stablecoin can actually move value on a given leg of a transaction without triggering a compliance failure on one side of it.

How should an institution operating across both jurisdictions respond?

• Treat GENIUS Act and MiCA compliance as two separate, non-transferable checks for any stablecoin used cross-border — confirm both independently rather than assuming one implies the other.
• Track each jurisdiction's authorised-issuer list directly rather than relying on a token's brand recognition; MiCA's authorised EMT/ART list and GENIUS Act licensed-issuer status both change as authorisations are granted or withdrawn.
• Build settlement routing that can select a different, locally compliant stablecoin per corridor rather than assuming one token works everywhere — the delisting pattern already seen in the EU makes this a near-term operational reality, not a hypothetical.
• Watch the 1 July 2026 MiCA transitional deadline specifically if any counterparty or liquidity provider is relying on Article 143 transitional status rather than full authorisation.
• Build compliance evidence (Travel Rule data, sanctions screening, reserve and redemption verification) once, in a form that satisfies both regimes' underlying intent, rather than maintaining separate compliance stacks per jurisdiction.

Where StableNet fits

StableNet settles across multiple stablecoins and chains rather than committing an institution to a single issuer, which is precisely the flexibility a GENIUS Act/MiCA-divided market requires: a corridor into the US can settle in a GENIUS Act-compliant payment stablecoin while a corridor into the EU settles in a MiCA-authorised EMT, with the same Travel Rule, sanctions screening and audit trail attached to both, rather than forcing a single token choice to work everywhere it structurally cannot.